Free Trial

GlucoTrack (GCTK) Competitors

GlucoTrack logo
$0.16 -0.01 (-3.05%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.16 +0.00 (+0.63%)
As of 04/17/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GCTK vs. QTI, XAIR, LFWD, VVOS, NRXS, PETV, PAVM, CODX, ALUR, and PSTV

Should you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include QT Imaging (QTI), Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), NeurAxis (NRXS), PetVivo (PETV), PAVmed (PAVM), Co-Diagnostics (CODX), Allurion Technologies (ALUR), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry.

GlucoTrack vs.

QT Imaging (NASDAQ:QTI) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

QT Imaging has higher revenue and earnings than GlucoTrack.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M4.75-$4.03MN/AN/A
GlucoTrackN/AN/A-$7.10M-$56.600.00

In the previous week, GlucoTrack had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for GlucoTrack and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.15 beat GlucoTrack's score of 0.25 indicating that QT Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GlucoTrack
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 46.5% of GlucoTrack shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

QT Imaging's return on equity of 0.00% beat GlucoTrack's return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
GlucoTrack N/A -826.43%-707.26%

QT Imaging and GlucoTrack both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
QT ImagingN/AN/A
GlucoTrackN/AN/A

QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500.

Summary

QT Imaging beats GlucoTrack on 7 of the 9 factors compared between the two stocks.

Get GlucoTrack News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCTK vs. The Competition

MetricGlucoTrackSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.07M$4.07B$5.31B$7.35B
Dividend YieldN/A46.48%5.45%4.34%
P/E Ratio0.0028.0921.9417.82
Price / SalesN/A47.06380.6697.73
Price / CashN/A51.0838.2534.64
Price / Book0.015.816.453.98
Net Income-$7.10M$67.09M$3.22B$247.81M
7 Day Performance-6.47%0.39%0.74%0.28%
1 Month Performance-46.73%-11.90%-9.66%-7.60%
1 Year Performance-99.81%15.43%11.81%1.49%

GlucoTrack Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCTK
GlucoTrack
1.2342 of 5 stars
$0.16
-3.0%
N/A-99.8%$4.07MN/A0.005
QTI
QT Imaging
N/A$0.61
+1.7%
N/A-15.6%$16.55M$4.00M0.00N/APositive News
Gap Up
XAIR
Beyond Air
4.2789 of 5 stars
$0.23
-1.7%
$3.67
+1,494.2%
-80.5%$15.82M$3.02M-0.2270
LFWD
ReWalk Robotics
2.4866 of 5 stars
$1.42
-1.4%
$9.00
+533.8%
-70.3%$15.10M$25.66M-0.5760Short Interest ↓
VVOS
Vivos Therapeutics
1.5705 of 5 stars
$2.27
+0.9%
$6.10
+168.7%
-22.8%$13.37M$15.03M-0.40160Analyst Forecast
News Coverage
NRXS
NeurAxis
N/A$1.85
+6.9%
N/A-47.6%$13.35M$2.69M-1.0119Gap Up
PETV
PetVivo
N/A$0.55
+9.9%
N/A-24.4%$13.07M$1.05M-1.2220High Trading Volume
PAVM
PAVmed
3.7681 of 5 stars
$0.71
-1.4%
$19.00
+2,576.4%
-61.8%$12.13M$3.00M-0.1690Short Interest ↑
Negative News
CODX
Co-Diagnostics
3.8651 of 5 stars
$0.36
-0.4%
$1.00
+177.0%
-69.8%$12.12M$3.92M-0.26100Short Interest ↓
Gap Up
ALUR
Allurion Technologies
2.1529 of 5 stars
$2.49
-2.7%
$22.83
+817.0%
-95.3%$11.94M$32.11M-0.21501Short Interest ↑
Gap Up
PSTV
Plus Therapeutics
1.7394 of 5 stars
$0.68
+6.3%
$11.17
+1,542.2%
-59.6%$11.56M$4.91M-0.2720Short Interest ↑
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:GCTK) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners